Offspring Biosciences
Stockholm, Sweden· Est.
A pharma-grade partner for De-Risking antibody validation. Specialist human tissue services including isPLA, multiplex IHC, AI-quant analysis, and non-GLP Pre-TCR studies. CRO
Private Company
Total funding raised: $2.5M
About
A pharma-grade partner for De-Risking antibody validation. Specialist human tissue services including isPLA, multiplex IHC, AI-quant analysis, and non-GLP Pre-TCR studies. CRO
Cell TherapyRegenerative Medicine
Funding History
1Total raised:$2.5M
Seed$2.5M